Aspirin in very low doses inhibits the formation of: September 2006
**Core Concept**
Aspirin, also known as acetylsalicylic acid, is a nonsteroidal anti-inflammatory drug (NSAID) that exerts its effects through the inhibition of prostaglandin synthesis. In low doses, aspirin selectively inhibits the enzyme cyclooxygenase-1 (COX-1), which plays a crucial role in platelet aggregation and blood clot formation.
**Why the Correct Answer is Right**
The correct answer involves the inhibition of thromboxane A2 production. Thromboxane A2 is a potent vasoconstrictor and platelet aggregator produced by platelets through the action of COX-1. When aspirin inhibits COX-1, it prevents the formation of thromboxane A2, thereby reducing platelet aggregation and blood clot formation. This selective inhibition of COX-1 is the mechanism behind aspirin's antiplatelet effect, which is beneficial in preventing cardiovascular events such as myocardial infarction and stroke.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because aspirin's effect on COX-2 is not relevant to its antiplatelet activity. COX-2 is primarily involved in the production of prostaglandins in inflammatory tissues, and its inhibition is not the primary mechanism behind aspirin's antiplatelet effect.
**Option B:** This option is incorrect because the inhibition of prostaglandin synthesis is a broader effect of aspirin, not specific to its antiplatelet activity. While aspirin does inhibit prostaglandin synthesis, this is not the specific mechanism behind its antiplatelet effect.
**Option C:** This option is incorrect because the inhibition of platelet aggregation is the direct result of aspirin's inhibition of COX-1 and the subsequent reduction in thromboxane A2 production.
**Clinical Pearl / High-Yield Fact**
Aspirin's antiplatelet effect is a key mechanism behind its cardiovascular benefits, and it is often used in low doses (81-100 mg) for the prevention of cardiovascular events. It is essential to note that high doses of aspirin can inhibit both COX-1 and COX-2, leading to gastrointestinal side effects and an increased risk of bleeding.
**Correct Answer: D.**